Please login to the form below

Not currently logged in
Email:
Password:

Grayling CEO Pete Pedersen resigns

He steps down after two years in role at Huntsworth company

Pete PedersenPete Pedersen has resigned from his role as CEO at communications company Grayling

Grayling's parent company Huntsworth released a statement last week that thanked Pedersen for repositioning the firm as a “digitally focused international PR company” and wishing him the best for the future. The executive management team of Grayling will manage the company on a day-by-day basis.

No official reason was given for Pedersen's departure although he did say on Twitter: “Resigned today. Time for my next great adventure. Best of luck to the entire @graylingpr team. Keep moving #onward.”

Huntsworth is already dealing with changes at the top with the decision by CEO Lord Chadlington to retire in April. It will be down to his successor Paul Taaffe to lead the hunt for a new CEO of Grayling, which works across numerous industries including healthcare.

Pederson joined Grayling in February 2013 after leaving his role as chair of the global technology practice at PR firm Edelman. Prior to this he served as executive VP and global client leader at Edelman where he led the launches of Microsoft products Xbox 360 and Halo 2.

26th January 2015

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...